Company Profile

PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE1411.4522.35 (+1.61 % )
PREV CLOSE (Rs.) 1389.10
OPEN PRICE (Rs.) 1392.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 65277
TODAY'S LOW / HIGH (Rs.)1389.00 1430.70
52 WK LOW / HIGH (Rs.)608 2050.01
NSE1411.05 21 (+1.51 % )
PREV CLOSE(Rs.) 1390.05
OPEN PRICE (Rs.) 1403.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1411.05 (2285 )
VOLUME 1660477
TODAY'S LOW / HIGH(Rs.) 1388.10 1431.30
52 WK LOW / HIGH (Rs.)606.85 2050.88

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.01
Dividend Yield(%) 0.99
TTM EPS (Rs.) 6.42
P/E Ratio 219.77
Book Value (Rs.) 1003.29
Face Value (Rs.) 2
MCap (Rs. in Mn) 318336.02
Price/Earning (TTM) 99.38
Price/Sales (TTM) 7.54
Price/Book (MRQ) 1.41
PAT Margin (%) -23.48
ROCE (%) 1.93
Incorporation Year : 1947

Management Info :

Ajay G Piramal - Chairman - Managing Director

Registered Office :

Address : Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone : 022 3802 3000/4000

Website : www.piramal.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
29Jun06-29-2020$ITI, Mahindra Logistics and Coal India to see some action today ITI, Mahindra Logistics and

ITI and Tech Mahindra have signed a Memorandum of Understanding (MoU) to work together in the areas of 4G & 5G smart networks, Smart Cities and Health Care services, in order to supplement country's requirement of self-reliance in the area of Telecommunication. ITI and Tech Mahindra will collaborate to create ‘Make in India’ stack as part of this MoU for the upcoming 4G & 5G opportunities in India.

Mahindra Logistics’ board has approved further investment in Lords Freight (India), subsidiary company by way of purchase of 3,80,970 equity shares of Lords (representing 16.13% of equity share capital of Lords) from the existing promoter shareholders of Lords. Presently, the company holds 82.92% of the share capital of Lords and on completion of the transfer formalities of said 3,80,970 equity shares of Lords, the company's shareholding in Lords would increase by 16.13%. The Investment Committee of the Board of Directors of the company at their Meeting held on June 27, 2020, has approved the same.

Coal India’s subsidiary -- Northern Coalfields (NCL) is looking to pump in Rs 7,000 crore over the next four years to ramp up production capacity and boost infrastructure at various projects. Of this amount, an investment of about Rs 3,000 crore is planned for procurement of heavy earthmoving machines and another Rs 3,000 crore will be used for development of additional coal evacuation-related infrastructure. Around Rs 200 crore will be used in developing 50 MW solar power plant.

Adani Green Energy has received shareholders' approval to raise Rs 2,500 crore in its fifth annual general meeting held on June 25, 2020. The company also got shareholders’ nod to have flexibility to infuse additional capital to tap capital markets and to raise additional long term resources, if necessary, in order to sustain rapid growth in the business, for business expansion and to improve the financial leveraging strength of the firm.

Dr Reddy's Laboratories is expecting to launch 25 products in the US market in the current financial year (FY21). The drug major has also earmarked a capital expenditure (capex) of Rs 1,000 crore for finding various projects during the ongoing financial year. Besides, the drug maker is also working on various biosimilar products, including, the Rituximab Phase III trial is progressing as per plan. And, in parallel, it is working on multiple other biosimilar products, which are at different stage of development.

CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, an investment fund managed and advised by affiliated entities of The Carlyle Group Inc. has agreed to invest fresh equity capital for a 20% stake in Piramal Enterprises’ wholly owned subsidiary -- Piramal Pharma. The estimated equity capital investment in Piramal Pharma would amount to over Rs 3,700 crore. The final amount of equity investment will depend on the net debt, exchange rate and performance against the pre-agreed conditions at the time of closing of the deal.

IDBI bank has received an approval to sell its stake held in IDBI Federal Life Insurance Company (IFLI) to the extent of 23% to Ageas and 4% to Federal Bank at a combined value of about Rs 595 crore. The meeting of Board of Directors of the bank held on June 26, 2020, approved the same.

ITI and Tech Mahindra have signed a Memorandum of Understanding..
29Jun06-29-2020$Piramal Enterprises gains as Carlyle Group to buy 20% stake in company’s arm Piramal Enterprises gains as

Piramal Enterprises is currently trading at Rs. 1359.60, up by 17.00 points or 1.27% from its previous closing of Rs. 1342.60 on the BSE.

The scrip opened at Rs. 1357.00 and has touched a high and low of Rs. 1364.90 and Rs. 1303.00 respectively. So far 135788 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2,049.50 on 04-Jul-2019 and a 52 week low of Rs. 608.00 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 1370.20 and Rs. 1164.50 respectively. The current market cap of the company is Rs. 29972.91 crore.

The promoters holding in the company stood at 46.06%, while Institutions and Non-Institutions held 39.11% and 14.83% respectively.

CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, an investment fund managed and advised by affiliated entities of The Carlyle Group Inc. has agreed to invest fresh equity capital for a 20% stake in Piramal Enterprises’ wholly owned subsidiary -- Piramal Pharma. The estimated equity capital investment in Piramal Pharma would amount to over Rs 3,700 crore. The final amount of equity investment will depend on the net debt, exchange rate and performance against the pre-agreed conditions at the time of closing of the deal.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises is currently trading at Rs. 1359.60, up by..
27Jun06-27-2020$Carlyle Group to buy 20% stake in Piramal Enterprises’ arm Carlyle Group to buy 20% sta
CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, an investment fund managed and advised by affiliated entities of The Carlyle Group Inc. has agreed to invest fresh equity capital for a 20% stake in Piramal Enterprises’ wholly owned subsidiary -- Piramal Pharma. The estimated equity capital investment in Piramal Pharma would amount to over Rs 3,700 crore. The final amount of equity investment will depend on the net debt, exchange rate and performance against the pre-agreed conditions at the time of closing of the deal.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

CA Clover Intermediate II Investments, an affiliated entity of..
26Jun06-26-2020$Piramal Enterprises raises Rs 2590 crore through bonds Piramal Enterprises raises R

Piramal Enterprises has raised Rs 2590 crore through unlisted, senior, secured, rated, redeemable nonconvertible bonds and allotted 25,900 bonds each having a face value of Rs 10,00,000 on private placement basis.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises has raised Rs 2590 crore through unlisted,..
24Jun06-24-2020$Piramal Enterprises gets nod to raise Rs 2,590 crore through bonds Piramal Enterprises gets nod

Piramal Enterprises’ board has approved raising up to Rs 2,590 crore through issuance of secured, rated, unlisted, redeemable nonconvertible bonds on private placement basis. The Administrative Committee of the Board of Directors of the company at its meeting held on June 23, 2020 has approved the same.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Enterprises’ board has approved raising up to Rs 2,59..
Financials More
Rs. in Millions
QTR Mar 20 ANNUAL 20
Net Profit-4842.81448.5
Gross Profit -1184.4 5398.4
Operating Profit 3224.524253.6
Net Sales 9887.142191.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Torrent Pharma (BSE)
 2394.70 (1.86%)
M.Cap ( in Cr)
40520.41
IOL Chem & Pharma (BSE)
 522.60 (6.45%)
M.Cap ( in Cr)
3067.95
Natco Pharma (BSE)
 663.05 (3.68%)
M.Cap ( in Cr)
12072.02
Medicamen Biotech (BSE)
 293.65 (5.69%)
M.Cap ( in Cr)
358.74
Suven Pharma (BSE)
 506.90 (2.93%)
M.Cap ( in Cr)
6451.95
Shareholding Pattern More
FI/BANKS/INSURANCE 8.77 %
PROMOTERS 46.06 %
NON-INSTITUTION 14.83 %
MUTUAL FUNDS/UTI 0.35 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes